Bolton, S., Harkness, M. & Thomson, S. (2011). ROTEM thromboelastometry identifies blood product requirements during major obstetric haemorrhage
Introduction: major obstetric haemorrhage (MOH) is a
significant cause of maternal morbidity and mortality. Despite a lack of published evidence, thromboelastometry has been r...
Harkness, M., Hayward, I., Mok, M. & Clark, V. (2010). Using a care pathway as part of an integrated approach to reduce inappropriate blood transfusion in stable postpartum women
Teig, M., Harkness, M., Catling, S. & Clark, V. (2007). Survey of cell-salvage use in obstetrics in the UK
Introduction: donor blood is a scarce and expensive
resource, and transfusion is not without risk.1
CEMACH2 and NICE3 have stated that cell salvage
should be considered in maj...
Bessos, H., Fagge, T., Wilson, D., Harkness, M., Rentoul, F., Ahya, R., …Turner, M. (2002). Neonatal alloimmune thrombocytopenia in Scotland: a national HPA-1 epidemiological study involving 26,506 pregnant women
Objective: Severe neonatal alloimmune thrombocytopenia
(NAITP) in the Caucasian population is mainly due to a mismatch in the HPA-I epitope between mother and fetus. In August...
Bessos, H., Turner, M., Fagge, T., Harkness, M., Rentoul, F., Seymour, J., …Urbaniak, S. (2002). Health economic evaluation of the cost effectiveness of antenatal screening for HPA-1 induced alloimmune thrombocytopenia (NAIT)
Background: The great majority of severe NAIT is due to HPA-1a antibodies (ab). However, due to uncertainties in clinical management and health economics, HPA-1 phenotyping of...
Harkness, M., Freer, Y. & Warner, P. (2016). Midwives' experience of offering anti-D immunoglobulin to women: the importance of choice. British Journal of Midwifery. 24(7), 500-505. doi:10.12968/bjom.2016.24.7.500. ISSN 0969-4900
Informed decision making around anti-D immunoglobulin (Ig) is important but complex, requiring consideration of individual factors to reach the most appropriate cho...
Walsh, T. S., Palmer, J., Watson, D., Biggin, K., Seretny, M., Davidson, H., …Hay, A. (2011). Multicentre cohort study of red blood cell use for revision hip arthroplasty and factors associated with greater risk of allogeneic blood transfusion. British Journal of Anaesthesia. 108, 63-71. doi:10.1093/bja/aer326. ISSN 0007-0912
Background Revision hip arthroplasty (RHA) is associated with high rates of allogeneic blood transfusion (ABT). We aimed to determine factors associated with ABT in patients u...
Harkness, M., Palmer, J. B., Watson, D. & Walsh, T. S. (2008). A questionnaire-based survey of perioperative blood conservation practice for revision hip arthroplasty in Scotland. Transfusion Medicine. 18, 296-301. doi:10.1111/j.1365-3148.2008.00883.x. ISSN 0958-7578
The aim of this study was to describe current blood conservation practice during revision hip surgery in Scotland and document practice variation. Revision hip surgery is asso...
Harkness, M., Freer, Y., Prescott, R. J. & Warner, P. (2008). Implementation of NICE recommendation for a policy of routine antenatal anti-D prophylaxis: a survey of UK maternity units. Transfusion Medicine. 18, 292-295. doi:10.1111/j.1365-3148.2008.00882.x. ISSN 0958-7578
The aim of this study was to determine how many UK maternity units have implemented National Institute for Clinical Excellence (NICE) guidance for routine antenatal anti-D pro...
Harkness, M. & Clark, V. (2008). The use of cell salvage during obstetric procedures: an audit of Scotland's maternity units. Scottish Medical Journal. 53, 24-27. ISSN 0036-9330
Concerns about the safety and supply of donor blood mean that clinicians are increasingly looking for alternatives to allogenic blood transfusion. One such altern...
Turner, M. L., Bessos, H., Fagge, T., Harkness, M., Rentoul, F., Seymour, J., …Urnaniak, S. (2005). Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a. Transfusion. 45, 1945-1956. doi:10.1111/j.1537-2995.2005.00645.x. ISSN 0041-1132
To assess the value of antenatal screening to detect neonatal alloimmune thrombocytopenia (NAIT) due to anti-HPA-1a, a prospective study was carried out to quantify the potent...
Harkness, M. (2001). Neonatal alloimmune thrombocytopenia. British Journal of Midwifery. 10, 99-103. doi:10.12968/bjom.2002.10.2.10195. ISSN 0969-4900
Neonatal alloimmune thrombocytopenia (NAIT) affects one in every 1000–2000 live births. Intracranial haemorrhage is the most serious complication of this condition, but the se...
Bessos, H., Fagge, T., Thompson, A., Wilson, D. & Harkness, M. Neonatal alloimmune thrombocytopenia (NAIT) in Scotland: epidemiological study involving 26,508 pregnant women.. Poster presented at Annual Scientific Meeting of the British Blood Transfusion Society., Leeds, United Kingdom. (Unpublished)
Bessos, H., Fagge, T., Wilson, D., Harkness, M., Rentoul, F., Armstrong-Fisher, S., …Turner, M. NAIT in Scotland: a large scale HPA-1 epidemiological study: Update. Transfusion, 40S, 2000.. Poster presented at 53rd Meeting of the American Association of Blood Banks., Washington D.C. (Unpublished)
Bessos, H., Fagge, T., Wilson, D., Harkness, M. & Rentoul, F. Update on the Scottish HPA-1 epidemiological study on neonatal alloimmune thrombocytopenia: results from 16,500 tests. Blood 96S, 2000.. Poster presented at 42nd Meeting of the American Society of Hematology., San Francisco. (Unpublished)